Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours-Reference-Cited by-同舟云学术

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours

Published:2017-11-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zhang Xia¹,Chuai Yunhai²,Nie Wei³,Wang Aiming²,Dai Guanghai¹

Affiliation:

1. Chinese PLA General Hospital; Department of Oncology; Beijing China

2. Navy General Hospital; Department of Obstetrics and Gynaecology; Fucheng Road Beijing China 100048

3. No.425 Hospital of Chinese PLA; Department of Internal Medicine; Sanya Bay Road No.86 Sanya China 572000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference92 articles.

1. 497115/003 A double-blind, randomized, multicenter, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and pharmacokinetics of an oral thrombopoietin receptor agonist (SB497115-GR) administered at 50, 75, and 100 mg to cancer patients receiving multiple cycles of chemotherapy GlaxoSmithKline (GSK) Clinical Study Register

2. Bussel JB McHutchison J Provan D Jagiello-Gruzfeld A Rafi R Goodison S Safety of eltrombopag, an oral non-peptide platelet growth factor, in the treatment of thrombocytopenia: results of four randomized, placebo-controlled studies Blood 2007 Nov 1299

3. Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia;Hayes;Cancer Chemotherapy and Pharmacology,2013 Jun

4. A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors;Kellum;Current Medical Research and Opinion,2010 Oct

5. Kellum A Jagiello-Gruszfeld A Bondarenko IN Rafi R Giangiulio P Messam C Hepatobiliary (HB) safety of eltrombopag administered after carboplatin+paclitaxel (Carb+Pac) in patients (pts) with solid tumors Journal of Clinical Oncology 2009 abstr e20667

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16/Akt signalling of haematological patients with chemotherapy‐induced thrombocytopenia;British Journal of Haematology;2024-08-27

2. Single-dose Administration of Recombinant Human Thrombopoietin Enhances Survival and Hematopoietic Reconstruction in Canines Irradiated with 3 Gy Gamma Radiation;Radiation Research;2024-04-29

3. A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study;Cancer;2024-03-22

4. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells;ACS Pharmacology & Translational Science;2023-11-15

5. Effects of thrombopoietin pre-treatment on peri-liver transplantation thrombocytopenia in a mouse model of cirrhosis with hypersplenism;World Journal of Gastrointestinal Surgery;2023-10-27